title: Severe worsening of parkinsonism in Lewy body dementia due to donepezil.
authors.forename: Luca
authors.initials: L
authors.lastname: Rozzini
authors.forename: Diego
authors.initials: D
authors.lastname: Ghianda
authors.forename: Marco
authors.initials: M
authors.lastname: Trabucchi
authors.forename: Alessandro
authors.initials: A
authors.lastname: Padovani
mesh_terms: D000109:Acetylcholine / Q000378:metabolism; D000368:Aged; D001479:Basal Ganglia / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D018450:Disease Progression; D000077265:Donepezil; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D005260:Female; D006801:Humans; D007189:Indans / Q000008:administration & dosage / Q000009:adverse effects*; D020961:Lewy Body Disease / Q000188:drug therapy*; D020734:Parkinsonian Disorders / Q000139:chemically induced* / Q000503:physiopathology; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D000077265:Donepezil; D000109:Acetylcholine; D004298:Dopamine